WHO ICTRP trial
Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed…
EUCTR2005-000393-47-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000393-47-IT |
|---|---|
| Public title | Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-controlled, crossover study. |
| Scientific title | Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-controlled, crossover study. |
| Primary sponsor | AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Treatment of spasticity in patients with Multiple Sclerosis MedDRA version: 9.1 Level: LLT Classification code 10028245 Term: Multiple sclerosis |
| Interventions | Trade Name: Cannabis Based Medicine Extract (Sativex) Pharmaceutical Form: Oromucosal spray Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2.7- |
| Registration date | May 3, 2007 |
| Secondary IDs | SP000680 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: